Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
India · Delayed Price · Currency is INR 78.39
+0.92 (1.19%)
At close: Jul 31, 2026
BOM:524412 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 39.68 | 40.24 | 46.84 | 37.71 | 65.55 |
Depreciation & Amortization | 28.53 | 19.45 | 16.98 | 15.74 | 19.88 |
Other Operating Activities | 48.56 | 48.34 | 30.44 | 28.27 | 18.82 |
Change in Accounts Receivable | 38.09 | 509.96 | 53.02 | -534.97 | 257.29 |
Change in Inventory | 39.44 | -108.05 | -58.57 | -151.35 | 47.77 |
Change in Accounts Payable | -209.52 | -264.02 | 16.12 | 176.7 | -6.78 |
Change in Income Taxes | 1.91 | 0.77 | -4.58 | -8.24 | 9.43 |
Change in Other Net Operating Assets | 114.71 | -143.68 | -130.18 | 423.33 | -406.97 |
Operating Cash Flow | 101.39 | 103 | -29.94 | -12.81 | 4.99 |
Operating Cash Flow Growth | -1.57% | - | - | - | -90.89% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -124.11 | -52.04 | -7.22 | -10.44 | -22.01 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.05 |
Investment in Securities | - | -7.35 | -9.8 | 14.85 | -23.89 |
Other Investing Activities | - | - | - | - | 13.75 |
Investing Cash Flow | -124.11 | -59.39 | -17.02 | 4.41 | -32.1 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 9.75 | - | - | 10.21 | - |
Long-Term Debt Repaid | -10.13 | -12.38 | -11.36 | - | - |
Net Debt Issued (Repaid) | -0.38 | -12.38 | -11.36 | 10.21 | - |
Issuance of Common Stock | 79.75 | 16.51 | 105.14 | - | 82.32 |
Other Financing Activities | -57.41 | -48.95 | -37.93 | 3.33 | -59.79 |
Financing Cash Flow | 21.97 | -44.82 | 55.85 | 13.54 | 22.53 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | -0 | - |
Net Cash Flow | -0.75 | -1.21 | 8.89 | 5.14 | -4.58 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -22.72 | 50.96 | -37.16 | -23.25 | -17.03 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -0.48% | 1.07% | -0.92% | -0.56% | -0.34% |
Free Cash Flow Per Share | -0.80 | 1.80 | -1.46 | -0.91 | -0.71 |
Levered Free Cash Flow | -294.91 | -157.35 | -21.19 | -288.63 | 71.5 |
Unlevered Free Cash Flow | -263.65 | -135.21 | 5.03 | -272.75 | 82.83 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 50.02 | 35.42 | 41.95 | 25.4 | 19.1 |
Cash Income Tax Paid | 15.92 | 19.09 | 13.25 | 22.79 | 35.9 |
Change in Working Capital | -15.37 | -5.02 | -124.19 | -94.53 | -99.27 |